financetom
Business
financetom
/
Business
/
Update: --Shareholders Vote for 3 Ancora-backed Norfolk Southern Board Nominees, Preliminary Results Show
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: --Shareholders Vote for 3 Ancora-backed Norfolk Southern Board Nominees, Preliminary Results Show
May 9, 2024 6:21 AM

09:12 AM EDT, 05/09/2024 (MT Newswires) --

Price: 217.50, Change: -14.64, Percent Change: -6.31

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
ADF Group Q3 Profit Beats Forecast, Revenue Falls
ADF Group Q3 Profit Beats Forecast, Revenue Falls
Dec 12, 2024
08:01 AM EST, 12/12/2024 (MT Newswires) -- ADF Group ( ADFJF ) on Thursday reported higher third-quarter profit that beat the consensus forecast, while revenue dipped slightly. The design and engineering services firm said net income rose to $16.4 million, or $0.55 per share, from $11.2 million, or $0.34 per share. The result beat the consensus $0.34 estimate by FactSet....
Stellantis to align to ACEA proposals after rejoining lobby group
Stellantis to align to ACEA proposals after rejoining lobby group
Dec 12, 2024
TURIN, Dec 12 (Reuters) - Stellantis ( STLA ) decision to rejoin the European auto lobby ACEA means the carmaker will immediately align itself with the group's proposals, Stellantis' ( STLA ) Europe Chief Jean-Philippe Imparato said on Thursday. Stellantis ( STLA ) last week said it would rejoin ACEA, which it left at the beginning of 2023. Under Chief...
MetLife Expects Double-Digit Adjusted EPS Growth Over Next 5 Years
MetLife Expects Double-Digit Adjusted EPS Growth Over Next 5 Years
Dec 12, 2024
08:02 AM EST, 12/12/2024 (MT Newswires) -- MetLife ( MET ) said Thursday that it expects double-digit adjusted earnings per share growth over the next five years. Under its five-year plan, the insurance company also expects an adjusted return on equity of 15% to 17%, a 100-basis-point reduction in direct expense ratio target, and free cash flow of $25 billion....
Unsupported price hikes added $815 million to US drug spending in 2023
Unsupported price hikes added $815 million to US drug spending in 2023
Dec 12, 2024
(Reuters) - Price increases for five of the 10 drugs that contributed the most to a rise in U.S. medical spending in 2023 were not supported by clinical evidence and drove costs higher by $815 million, an influential drug pricing watchdog said on Thursday. The Institute for Clinical and Economic Review (ICER) said that half of the drugs assessed had...
Copyright 2023-2026 - www.financetom.com All Rights Reserved